A look at The First Company Likely to Market an FDA Approved Cannabinoid in the US

On April 19th an FDA advisory committee voted unanimously to recommend approval of the first prescription cannabidiol medicine — to treat rare and severe forms of epilepsy. The drug is known as Epidiolex. The company behind Epidiolex is GW Pharmaceuticals.